Maravai LifeSciences Holdings Inc
NASDAQ:MRVI

Watchlist Manager
Maravai LifeSciences Holdings Inc Logo
Maravai LifeSciences Holdings Inc
NASDAQ:MRVI
Watchlist
Price: 5.3 USD 3.31% Market Closed
Market Cap: 1.3B USD
Have any thoughts about
Maravai LifeSciences Holdings Inc?
Write Note

Maravai LifeSciences Holdings Inc
Investor Relations

Maravai LifeSciences Holdings Inc. operates in the niche yet burgeoning market of life sciences, where its business revolves around the creation and supply of essential products and services for biotechnology workflows. Founded in 2014 and headquartered in San Diego, California, Maravai specializes in providing key components for the development of diagnostics and therapeutics. A significant portion of its revenue is driven by its business unit, TriLink BioTechnologies, which is instrumental in the synthesis of nucleic acids, notably mRNA and modified nucleotides – critical for the development of mRNA vaccines like those used in combating COVID-19. This has positioned Maravai as a crucial player during the pandemic, spotlighting its capability to provide high-quality inputs that support leading-edge scientific innovations.

The company’s financial engine is powered by its diversified product offerings across three main segments: Nucleic Acid Production, Biologics Safety Testing, and Protein Detection. Beyond just supplying raw materials, Maravai elevates its contributions by ensuring these components meet rigorous quality standards necessary for clinical applications. The robust demand for both biopharmaceutical innovation and bioprotection has allowed Maravai to capitalize on trends such as personalized medicine and gene therapy. By navigating these influential currents in the biotechnology space, Maravai LifeSciences not only gains from direct sales of its products but also cultivates long-standing partnerships across pharmaceutical and research organizations, underscoring its integral role in the ongoing evolution of life sciences.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Mr. Carl W. Hull
Co-Founder & Executive Chairman
No Bio Available
Mr. William E. Martin III
CEO & Director
No Bio Available
Mr. Kevin M. Herde CPA
Executive VP & CFO
No Bio Available
Dr. Peter Michael Leddy Ph.D.
Executive VP & Chief Administrative Officer
No Bio Available
Ms. Christine Dolan
Executive VP & GM of Cygnus Technologies
No Bio Available
Mr. Andrew Burch
President of Nucleic Acid Production
No Bio Available
Ms. Debra Hart
Senior Director of Investor Relations
No Bio Available
Ms. Rebecca Buzzeo
Executive VP & Chief Commercial Officer
No Bio Available
Dr. Kate E. Broderick Ph.D.
Chief Innovation Officer
No Bio Available

Contacts

Address
CALIFORNIA
San Diego
10770 Wateridge Circle Suite 200, Suite 200
Contacts
+18585460004.0
www.maravai.com